Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study

Three-year treatment with budesonide once daily (200 or 400 μg) is safe and well tolerated in children and adults with newly detected mild persistent asthma.